Effectiveness of SDF With Different Post-treatment Protocols in Arresting Dental Caries
Launched by THE UNIVERSITY OF HONG KONG · Dec 8, 2022
Trial Information
Current as of January 21, 2025
Completed
Keywords
ClinConnect Summary
Methods: The randomized clinical trial will recruit 254 healthy kindergarten children aged 3-4 years old with caries and with parental consent. All the tooth surfaces with carious lesions will receive the semi-annual application of 38% SDF solution. After the treatment, children will be allocated to two groups by an independent research assistant. Two post-treatment protocols are as follows.
Group A - Children are instructed to rinse their teeth with a cup of water containing about 50 ml immediately after SDF treatment. Afterwards, no post-treatment protocol is given to children.
Group B ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 3-5 year old children attending the first to the third year of kindergarten;
- • 2. free from any systemic conditions and generally healthy;
- • 3. parents sign informed consent;
- • 4. having at least 1 tooth with cavitated dentine carious lesion
- Exclusion Criteria:
- • 1. are uncooperative to accept oral examination or treatment;
- • 2. have a significant systematic disease or long-term medications;
- • 3. have abnormal dentition.
- • 4. Teeth having signs or symptoms of irreversible pulpitis and non-vitality will be excluded.
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials